InvestorsHub Logo
Followers 23
Posts 585
Boards Moderated 0
Alias Born 12/19/2020

Re: CrashOverride post# 451220

Monday, 03/14/2022 7:35:24 PM

Monday, March 14, 2022 7:35:24 PM

Post# of 700966
Redneck, I'm not certain what you ask. We know the SAP is already amended:

"The primary objective of this study is to compare overall survival (OS) between patients randomized to DCVax-L and control patients from comparable, contemporaneous trials who received standard of care therapy only, in patients with newly diagnosed glioblastoma. This endpoint will be assessed using 3 different analyses"

The details of these comparable "historical" trials are what are going to make the dc-Vax data irrefutably ground breaking in comparison.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News